透析诱导的心血管及多器官损伤
本文综述了当前间歇性血液透析治疗对患者全身的不良影响及其病理生理后果。血液透析本身可能通过系统性循环应激导致多器官损伤,叠加于原有合并症之上,并影响症状负担、认知功能和生活质量。文章还回顾了心脏保护性干预措施的证据,并探讨了可能进一步减轻透析全身负担的新方法。
要点
- 血液透析可导致系统性循环应激,引起多器官损伤。
- 透析中低血容量、低血压、低氧血症、溶质和电解质波动及心律失常是 contributing factors。
- 这些因素增加症状负担、损害认知功能并降低生活质量。
核心结论
- 血液透析本身可能通过系统性循环应激导致多器官损伤,叠加于原有合并症,并影响患者预后。
研究设计与样本
- 本文为综述,总结了当前间歇性血液透析治疗的不良全身效应及其病理生理后果。
主要发现
- 新的功能成像(如超声心动图、心脏MRI)和特定心脏生物标志物(如肌钙蛋白I)动力学已明确记录透析相关的终末器官损伤。
- 透析中低血容量、低血压发作、低氧血症、溶质和电解质通量以及心律失常是系统性循环应激的 contributing factors。
- 这些因素导致患者症状负担、损害认知功能,并对患者感知和生活质量产生负面影响。
临床怎么用
- 临床应关注透析中的循环应激因素,并考虑心脏保护性干预措施。
- 可探索改进的生物相容性材料、智能透析机、健康追踪器等新方法以减轻透析的全身负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hemodialysis has saved many lives, albeit with significant residual mortality. Although poor outcomes may reflect advanced age and comorbid conditions, hemodialysis per se may harm patients, contributing to morbidity and perhaps mortality. Systemic circulatory "stress" resulting from hemodialysis treatment schedule may act as a disease modifier, resulting in a multiorgan injury superimposed on preexistent comorbidities. New functional intradialytic imaging (i.e., echocardiography, cardiac magnetic resonance imaging [MRI]) and kinetic of specific cardiac biomarkers (i.e., Troponin I) have clearly documented this additional source of end-organ damage. In this context, several factors resulting from patient-hemodialysis interaction and/or patient management have been identified. Intradialytic hypovolemia, hypotensive episodes, hypoxemia, solutes, and electrolyte fluxes as well as cardiac arrhythmias are among the contributing factors to systemic circulatory stress that are induced by hemodialysis. Additionally, these factors contribute to patients' symptom burden, impair cognitive function, and finally have a negative impact on patients' perception and quality of life. In this review, we summarize the adverse systemic effects of current intermittent hemodialysis therapy, their pathophysiologic consequences, review the evidence for interventions that are cardioprotective, and explore new approaches that may further reduce the systemic burden of hemodialysis. These include improved biocompatible materials, smart dialysis machines that automatically may control the fluxes of solutes and electrolytes, volume and hemodynamic control, health trackers, and potentially disruptive technologies facilitating a more personalized medicine approach.
引用
- Canaud B, Kooman JP, Selby NM, et al. Dialysis-Induced Cardiovascular and Multiorgan Morbidity. Kidney Int Rep. 2020. PMID: 33163709. doi:10.1016/j.ekir.2020.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。